Skip to Main content Skip to Navigation
Journal articles

Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin

Abstract : We attempted to prepare a subcutaneous pharmaceutical form of warfarin based on a suspension or poly(ε-caprolactone) microparticles to improve patient adherence. The warfarin suspension had a mean particle size of 20.0 μm and in vitro release close to 100% in 72 h. Microparticle size and encapsulation efficiencies ranged from 54.0 to 80.0 μm and 37.0 to 47.0%, respectively. After 72 h, warfarin microparticles exhibited in vitro drug release ranging from 62.0 to 80.0%. Warfarin subcutaneous dosage forms were administered to rabbits. Plasma concentration of warfarin was determined and biological activity was measured by prothrombin time monitoring. The observed relative bioavailabilities calculated from plasma concentrations and prothrombin times were 54.2 and 92.1%, and 61.8 and 61.4% for suspension and microparticles, respectively.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01491914
Contributor : Cithefor Ul <>
Submitted on : Friday, March 17, 2017 - 3:55:30 PM
Last modification on : Tuesday, February 23, 2021 - 1:22:01 PM

Identifiers

Collections

Citation

J. Scala-Bertola, L. Javot, A. Camargo, F. Bonneaux, T. Lecompte, et al.. Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin. International Journal of Pharmaceutics, Elsevier, 2012, 431 (1-2), pp.33 - 38. ⟨10.1016/j.ijpharm.2012.03.053⟩. ⟨hal-01491914⟩

Share

Metrics

Record views

113